Avenzo Therapeutics
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
12707 High Bluff Dr Ste 200, San Diego, ...Phone Number
(858) 239-2944Website
www.avenzotx.comRevenue
$10.6 MillionIndustry
About Avenzo Therapeutics
Avenzo Therapeutics Org Chart
Is Avenzo Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Avenzo Therapeutics has new funding data
Website visits: Recent activity has been detected on your website
Click to see if Avenzo Therapeutics had a recent Job posting/layoffs
Product Launch: Get notified when Avenzo Therapeutics launches new products
Congratulate Masked Content for being promoted to Masked Content at Avenzo Therapeutics
Check if Avenzo Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Avenzo Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Avenzo Therapeutics recently announced quarterly report
Check out if Avenzo Therapeutics is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Avenzo Therapeutics
Compare insights from companies similar to Avenzo Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Avenzo Therapeutics
Company Profile Activity
Activity Insights
Avenzo Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Avenzo Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Avenzo Therapeutics.
Avenzo Therapeutics financials insights
Gather financial insights about Avenzo Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series A
$380M
Private Equity
$47.2M
Series B
$60M
Avenzo Therapeutics Tech Stack
A closer look at the technologies used by Avenzo Therapeutics
Most Recent Scoops
Avenzo Therapeutics News & Media
RallyBio tries again for reverse merger, this time with Avenzo
It's the second attempt for the rare disease company, which initially announced plans to merge with Candid Therapeutics before the immune drug developer was bought by UCB.Rallybio strikes new merger agreement after previous deal collapsed
The deak would mark the end of Rallybio's Connecticut operations.Rallybio swerves past Candid pothole to land deal with Avenzo - Fierce Biotech
Rallybio has steered its way to a new merger, inking a deal with Avenzo Therapeutics weeks after a UCB buyout took its former partner off the market.Avenzo Therapeutics Announces Appointment of Scott Lipman as Chief Financial Officer
SAN DIEGO--(BUSINESS WIRE)--Nov 19, 2025--
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Avenzo Therapeutics
Avenzo Therapeutics is a biotechnology company focused on developing innovative therapies to treat solid tumor cancers, aiming to improve outcomes for cancer patients through cutting-edge science and clinical research.... Read More

